Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (613)	12/4/1997 2:25:00 PM
From: Ryan Weisman	Read Replies (1) \| Respond to of 1894

All this news is impressive, and your analysis is right on. However, I think there will be serious resistance to the stock at 2 and 2 1/4in the short run, until the next quarters release. But be patient my friends, things are turning and this stock will rise faster than it fell. We know there are great things on the horizon, but the street doesn't. Yet.

To: Frank Buck who wrote (613)	12/5/1997 1:57:00 PM
From: joemjo	Read Replies (1) \| Respond to of 1894

Frank, "what do I glean from the recent events?"? Well, I think they hired a PR firm to communicate with the investing public. I think that is good and clears away the fear of silence. I think the FDA approval was a good thing not a negative and the share price should have gone or at least not down. It is lower than it should be and the hot money looking for a big pop on the FDA approval is leaving. They are selling into a vaccuum because the earnings did not generate any interest or reason to stay. I believe that their products will sell at profit, that will be represented on future income statements, and the share price will rise. I am closer to buying than selling, but currently just holding. Last buy at 2 5/16. I do not understand their products from a user point of view. Todd